Thelansis

Social Anxiety Disorder (SAD) Emerging Therapy and TPP Insights Thelansis’s “Social Anxiety Disorder (SAD) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2025″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication . Key business questions answered: Detailed emerging competitive landscape Pipeline analysis Target patients for emerging therapies Key companies Key mechanism of actions Launch date estimates, etc. Clinical trial landscape analysis Target patient segments Trial endpoints Trial design Recruitment criteria, etc. Unmet Needs and Opportunities Performance of key current therapies Top areas of unmet needs Opportunity sizing for key unmet needs Target Product...

Social Anxiety Disorder (SAD) Emerging Therapy and TPP Insights Thelansis’s “Social Anxiety Disorder (SAD) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2024 To 2034″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication . Social Anxiety Disorder (SAD) Overview Social anxiety disorder (SAD) is a common mental health condition that causes people to feel intense anxiety in social situations. It can be divided into two subtypes: generalized SAD and non-generalized SAD. Generalized SAD is characterized by fear of most social situations. People with generalized SAD may worry about being judged, humiliated, or embarrassed in front of others. They may avoid social situations altogether, or they may experience extreme anxiety when they are forced to participate in social activities. ...